ES528537A0 - Procedimiento para la obtencion de pancreatina - Google Patents

Procedimiento para la obtencion de pancreatina

Info

Publication number
ES528537A0
ES528537A0 ES528537A ES528537A ES528537A0 ES 528537 A0 ES528537 A0 ES 528537A0 ES 528537 A ES528537 A ES 528537A ES 528537 A ES528537 A ES 528537A ES 528537 A0 ES528537 A0 ES 528537A0
Authority
ES
Spain
Prior art keywords
procedure
pancreatin
obtaining
obtaining pancreatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES528537A
Other languages
English (en)
Other versions
ES8407516A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordmark Werke GmbH
Original Assignee
Nordmark Werke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19823248587 external-priority patent/DE3248587A1/de
Priority claimed from DE19823248588 external-priority patent/DE3248588A1/de
Application filed by Nordmark Werke GmbH filed Critical Nordmark Werke GmbH
Publication of ES8407516A1 publication Critical patent/ES8407516A1/es
Publication of ES528537A0 publication Critical patent/ES528537A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
ES528537A 1982-12-30 1983-12-29 Procedimiento para la obtencion de pancreatina Granted ES528537A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823248587 DE3248587A1 (de) 1982-12-30 1982-12-30 Verfahren zur gewinnung von pankreatin
DE19823248588 DE3248588A1 (de) 1982-12-30 1982-12-30 Verfahren zur gewinnung von pankreatin von hohem schuettgewicht

Publications (2)

Publication Number Publication Date
ES8407516A1 ES8407516A1 (es) 1984-09-16
ES528537A0 true ES528537A0 (es) 1984-09-16

Family

ID=25807022

Family Applications (1)

Application Number Title Priority Date Filing Date
ES528537A Granted ES528537A0 (es) 1982-12-30 1983-12-29 Procedimiento para la obtencion de pancreatina

Country Status (15)

Country Link
US (1) US4623624A (es)
EP (1) EP0115023B1 (es)
AR (1) AR232000A1 (es)
BR (1) BR8307280A (es)
CA (1) CA1208580A (es)
DD (1) DD212981A5 (es)
DE (1) DE3377506D1 (es)
DK (1) DK173599B1 (es)
ES (1) ES528537A0 (es)
HU (1) HU196435B (es)
MD (1) MD411C2 (es)
PL (1) PL141118B1 (es)
SU (1) SU1644712A3 (es)
UA (1) UA5996A1 (es)
YU (1) YU45584B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030581C (en) * 1989-11-24 2000-06-27 Gunther Atzl Pancreatin preparations
CA2198317C (en) * 1997-02-24 2003-01-07 Mouhsine El Abboudi Method for preparing pancreatin which contains low amounts of residual organic solvent and product thereof
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
KR100367659B1 (ko) * 2000-05-08 2003-01-14 주식회사 바이넥스 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
CA2419572A1 (en) * 2003-02-18 2004-08-18 Axcan Pharma Inc. High dosage protease formulation
JP4891766B2 (ja) * 2003-07-29 2012-03-07 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング パンクレアチン及び比較可能な組成物のための分析法
AU2005227090B2 (en) * 2004-03-22 2010-12-09 Abbott Laboratories Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
US7153504B2 (en) * 2004-07-30 2006-12-26 Can Technologies, Inc. Stabilized pancreas product
CN101184780B (zh) 2005-05-05 2012-10-03 森馨香料公司 β-葡聚糖和甘露聚糖的制备
AU2006274835B2 (en) 2005-07-29 2012-05-24 Abbott Laboratories Gmbh Processes for the manufacture of sterilized pancreatin powder
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
TW200745337A (en) * 2006-02-24 2007-12-16 Aminotech As Modified process
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US8221747B2 (en) 2007-02-20 2012-07-17 Aptalis Pharma Limited Stable pancreatic enzyme compositions
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
ES2732453T3 (es) * 2008-07-01 2019-11-22 Curemark Llc Métodos y composiciones para el tratamiento de síntomas de trastornos neurológicos y de salud mental
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
EP2165717A1 (de) * 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
WO2010080835A1 (en) 2009-01-06 2010-07-15 Curemark Llc Compositions and methods for the treatment or the prevention oral infections by e. coli
AU2010203709B2 (en) 2009-01-06 2014-05-22 Galenagen, Llc Compositions and methods for the treatment or prevention of Staphylococcus Aureus infections and for the Eradication or reduction of Staphylococcus Aureus on surfaces
US9056050B2 (en) * 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
SI2621476T1 (sl) 2010-10-01 2014-12-31 Aptalis Pharma Limited Gastrorezistentne obloĹľene pankrelipazne formulacije z nizko trdnostjo
DK2701733T3 (da) 2011-04-21 2019-05-27 Curemark Llc Forbindelser til behandling af neuropsykiatriske forstyrrelser
ES2558756T3 (es) 2011-08-08 2016-02-08 Aptalis Pharma Limited Método para la prueba de disolución de composiciones sólidas que contienen enzimas digestivas
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
EP3024479B2 (en) * 2013-07-22 2023-02-08 Allergan Pharmaceuticals International Limited Methods of preparing pancreatin
ES2784227T3 (es) 2013-08-09 2020-09-23 Allergan Pharmaceuticals Int Ltd Composición de enzimas digestivos adecuada para la administración entérica
BR112016000658A2 (pt) * 2013-11-05 2018-03-20 Allergan Pharmaceuticals International Limited pancreatina de alta atividade, processo para a preparação de pancreatina de aa tendo atividade lipásica específica de pelo menos aproximadamente 120 usp iu/mg e método de tratamento de um paciente sujeito a uma condição patológica associada com a insuficiência enzimática pandreática
CA2947998A1 (en) 2014-06-19 2015-12-23 Aptalis Pharma Ltd. Methods for removing viral contaminants from pancreatic extracts
US20160120964A1 (en) 2014-11-05 2016-05-05 George Shlieout Processes for producing compositions with improved safety profile having lipase activity and compositions suitable for pharmaceutical use
US11278603B2 (en) 2016-03-28 2022-03-22 Abbvie Inc. Enzyme compositions with reduced viral and microbial contamination
WO2017172619A1 (en) 2016-03-28 2017-10-05 Abb Vie Inc. Enzyme compositions with reduced viral and microbial contamination
CN111630164A (zh) 2017-09-27 2020-09-04 雅培制药股份有限公司 具有减少的病毒和微生物污染的酶组合物
CN108316036A (zh) * 2018-01-25 2018-07-24 陕西科技大学 一种豆渣制备微纤化纤维素的方法
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
WO2024105193A1 (en) * 2022-11-17 2024-05-23 Koptyug Andrey V Novel compounds and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928654A (en) * 1960-10-25 1963-06-12 Philips Nv Improvements in or relating to the production of pancreatin
GB1328202A (en) 1969-06-17 1973-08-30 Union International Co Ltd Manufacture of pancreatin
DE2106706B2 (de) * 1971-02-12 1973-05-10 Wilson Pharmaceutical & Chemical Corp., Chicago, 111. (V.St.A.) Verfahren zur herstellung von pankreatin als trockenes pulver mit hoher proteolytischer, amylolytischer und lipolytischer aktivitaet
MX4738E (es) 1976-05-07 1982-08-25 Nattermann A & Cie Procedimiento para fabricar preparados enzimaticos ricos en lipasa
DE2620289C2 (de) * 1976-05-07 1982-05-19 A. Nattermann & Cie GmbH, 5000 Köln Herstellung eines lipasereichen Enzympräparates

Also Published As

Publication number Publication date
EP0115023B1 (de) 1988-07-27
CA1208580A (en) 1986-07-29
US4623624A (en) 1986-11-18
EP0115023A3 (en) 1986-04-09
YU45584B (sh) 1992-07-20
DK605583A (da) 1984-07-01
DK605583D0 (da) 1983-12-29
DD212981A5 (de) 1984-08-29
EP0115023A2 (de) 1984-08-08
HU196435B (en) 1988-11-28
ES8407516A1 (es) 1984-09-16
AR232000A1 (es) 1985-04-30
DE3377506D1 (en) 1988-09-01
UA5996A1 (uk) 1994-12-29
DK173599B1 (da) 2001-04-23
BR8307280A (pt) 1984-08-07
PL245381A1 (en) 1984-10-22
SU1644712A3 (ru) 1991-04-23
YU252483A (en) 1986-10-31
MD411C2 (ro) 1996-06-30
PL141118B1 (en) 1987-06-30

Similar Documents

Publication Publication Date Title
AR232000A1 (es) Procedimiento para la obtencion de pancreatina
ES555049A0 (es) Procedimiento para la obtencion de arilciclopropil-cetonas
ES527714A0 (es) Procedimiento para la obtencion de tetrapeptidos sustituidos
ES543386A0 (es) Procedimiento para la obtencion de 1-heteroaril-4-aril-pira-zolin-5-onas
ES542207A0 (es) Procedimiento para la obtencion de tetrahidrofuran-2-ilmeti-laminas
ES533538A0 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES520273A0 (es) Procedimiento para la obtencion de trimetilolpropano.
ES550219A0 (es) Procedimiento para la obtencion de aminopolieteres alcoxi- lados
ES545967A0 (es) Procedimiento para la obtencion de poliarilensulfuro
ES516841A0 (es) Procedimiento para la obtencion de benzofuranonas
ES549255A0 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
ES526042A0 (es) Procedimiento para la obtencion de azolilbutanoles
ES543820A0 (es) Procedimiento para la obtencion de piperacinil-oxo-quinoli- nas
ES533988A0 (es) Procedimiento para la obtencion de mercaptocarboxilamidas
ES525257A0 (es) Procedimiento para la obtencion de poliamido-imidas
ES549266A0 (es) Procedimiento para la obtencion de n-halo-carbonil-fenilhi- drazinas substituidas
ES522474A0 (es) Procedimiento para la obtencion de halogenopropargilformamidas.
ES546549A0 (es) Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas
ES526672A0 (es) Procedimiento para la obtencion de latex cationicos
ES519809A0 (es) Procedimiento para la obtencion de oxazolidin-2-onas.
ES537129A0 (es) Procedimiento para la obtencion de iodacetamidas
ES546192A0 (es) Procedimiento para la obtencion de benzotiazolsulfenamidas
ES525507A0 (es) Procedimiento para la obtencion de 2-benzotiazolsulfenamidas estericamente impedidas
ES525995A0 (es) Procedimiento de obtencion de piridopirimidinonas
ES555532A0 (es) Procedimiento para la obtencion de benzotiopiranonas